BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 38471824)

  • 21. Effects of Intensive BP Control in CKD.
    Cheung AK; Rahman M; Reboussin DM; Craven TE; Greene T; Kimmel PL; Cushman WC; Hawfield AT; Johnson KC; Lewis CE; Oparil S; Rocco MV; Sink KM; Whelton PK; Wright JT; Basile J; Beddhu S; Bhatt U; Chang TI; Chertow GM; Chonchol M; Freedman BI; Haley W; Ix JH; Katz LA; Killeen AA; Papademetriou V; Ricardo AC; Servilla K; Wall B; Wolfgram D; Yee J;
    J Am Soc Nephrol; 2017 Sep; 28(9):2812-2823. PubMed ID: 28642330
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular Risk of Isolated Systolic or Diastolic Hypertension in Young Adults.
    Lee H; Yano Y; Cho SMJ; Park JH; Park S; Lloyd-Jones DM; Kim HC
    Circulation; 2020 Jun; 141(22):1778-1786. PubMed ID: 32479205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association Between Systolic and Diastolic Blood Pressure Variability and the Risk of End-Stage Renal Disease.
    Bae EH; Lim SY; Han KD; Oh TR; Choi HS; Kim CS; Ma SK; Kim SW
    Hypertension; 2019 Oct; 74(4):880-887. PubMed ID: 31422691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. BP in Young Adults with CKD and Associations with Cardiovascular Events and Decline in Kidney Function.
    Kula AJ; Prince DK; Flynn JT; Bansal N
    J Am Soc Nephrol; 2021 May; 32(5):1200-1209. PubMed ID: 33692088
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is systolic blood pressure below 150 mm Hg an appropriate goal for primary prevention of cardiovascular events among elderly population?
    Mohebi R; Mohebi A; Ghanbarian A; Momenan A; Azizi F; Hadaegh F
    J Am Soc Hypertens; 2014 Jul; 8(7):491-7. PubMed ID: 25064771
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between More Intensive vs Less Intensive Blood Pressure Lowering and Risk of Mortality in Chronic Kidney Disease Stages 3 to 5: A Systematic Review and Meta-analysis.
    Malhotra R; Nguyen HA; Benavente O; Mete M; Howard BV; Mant J; Odden MC; Peralta CA; Cheung AK; Nadkarni GN; Coleman RL; Holman RR; Zanchetti A; Peters R; Beckett N; Staessen JA; Ix JH
    JAMA Intern Med; 2017 Oct; 177(10):1498-1505. PubMed ID: 28873137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood Pressure Classification of 2017 Associated With Cardiovascular Disease and Mortality in Young Chinese Adults.
    Wu S; Song Y; Chen S; Zheng M; Ma Y; Cui L; Jonas JB
    Hypertension; 2020 Jul; 76(1):251-258. PubMed ID: 32520626
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Office Blood Pressure Range and Cardiovascular Events in Patients With Hypertension: A Nationwide Cohort Study in South Korea.
    Kwon CH; Kim W; Shin JH; Lee CJ; Kim HC; Kang SH; Jung MH; Kim DH; Lee JH; Kim HL; Kim HM; Cho IJ; Cho I; Kang DR; Lee HY; Chung WJ; Ihm SH; Kim KI; Cho EJ; Sohn IS; Park S; Shin J; Ryu SK; Kang SM; Cho MC; Kim JH; Lee JH; Kim JY; Pyun WB; Sung KC
    J Am Heart Assoc; 2021 Apr; 10(7):e017890. PubMed ID: 33739126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Benefit and harm of intensive blood pressure treatment: Derivation and validation of risk models using data from the SPRINT and ACCORD trials.
    Basu S; Sussman JB; Rigdon J; Steimle L; Denton BT; Hayward RA
    PLoS Med; 2017 Oct; 14(10):e1002410. PubMed ID: 29040268
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blunted sleep-time relative blood pressure decline increases cardiovascular risk independent of blood pressure level--the "normotensive non-dipper" paradox.
    Hermida RC; Ayala DE; Mojón A; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):87-98. PubMed ID: 23039824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.
    Tajeu GS; Booth JN; Colantonio LD; Gottesman RF; Howard G; Lackland DT; O'Brien EC; Oparil S; Ravenell J; Safford MM; Seals SR; Shimbo D; Shea S; Spruill TM; Tanner RM; Muntner P
    Circulation; 2017 Aug; 136(9):798-812. PubMed ID: 28634217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Benefit of Treatment of Stage-1, Low-Risk Hypertension.
    Lee CJ; Ryu J; Kim HC; Ryu DR; Ihm SH; Kim YJ; Shin JH; Pyun WB; Kang HS; Park JH; Hwang J; Park S
    Hypertension; 2018 Dec; 72(6):1285-1293. PubMed ID: 30571236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of blood pressure index on clinical outcomes in patients with heart failure and chronic kidney disease.
    Yuan Y; Liu M; Zhang S; Lin Y; Huang Y; Zhou H; Xu X; Zhuang X; Liao X
    ESC Heart Fail; 2023 Dec; 10(6):3330-3339. PubMed ID: 37667525
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association of Daytime and Nighttime Blood Pressure With Cardiovascular Disease Events Among African American Individuals.
    Yano Y; Tanner RM; Sakhuja S; Jaeger BC; Booth JN; Abdalla M; Pugliese D; Seals SR; Ogedegbe G; Jones DW; Muntner P; Shimbo D
    JAMA Cardiol; 2019 Sep; 4(9):910-917. PubMed ID: 31411629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The association of BP with cardiovascular outcomes in patients with dipstick proteinuria and preserved kidney function.
    Suzuki Y; Kaneko H; Yano Y; Okada A; Fujiu K; Matsuoka S; Michihata N; Jo T; Takeda N; Morita H; Node K; Yasunaga H; Oparil S; Komuro I
    Hypertens Res; 2023 Apr; 46(4):856-867. PubMed ID: 36658302
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
    Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
    Hundemer GL; Knoll GA; Petrcich W; Hiremath S; Ruzicka M; Burns KD; Edwards C; Bugeja A; Rhodes E; Sood MM
    Am J Kidney Dis; 2021 Feb; 77(2):178-189.e1. PubMed ID: 32920153
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-World Systolic and Diastolic Blood Pressure Levels and Cardiovascular Mortality in Patients With Type 2 Diabetes-Results From a Large Registry Cohort in Asia.
    Seng LL; Hai Kiat TP; Bee YM; Jafar TH
    J Am Heart Assoc; 2023 Dec; 12(23):e030772. PubMed ID: 37930066
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lower Diastolic Blood Pressure was Associated with Higher Incidence of Chronic Kidney Disease in the General Population Only in those Using Antihypertensive Medications.
    Uchida D; Kido R; Kawarazaki H; Murasawa M; Ando A; Fujimoto S; Iseki K; Moriyama T; Yamagata K; Tsuruya K; Konta T; Narita I; Kondo M; Kasahara M; Asahi K; Watanabe T; Shibagaki Y
    Kidney Blood Press Res; 2019; 44(5):973-983. PubMed ID: 31487706
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute Declines in Estimated GFR in Blood Pressure Target Trials and Risk of Adverse Outcomes.
    Ku E; McCulloch CE; Copeland TP; Inker LA; Tighiouart H; Sarnak MJ
    Am J Kidney Dis; 2023 Oct; 82(4):454-463. PubMed ID: 37269972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.